Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Phase I Study of TRN501 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Parkinson Disease
- Interventions
- Drug: TRN501 - Dose 6Drug: TRN501 - Dose 4Drug: TRN501 - Dose 5Drug: TRN501 - Dose 1Drug: TRN501 - Dose 2Drug: TRN501 - Dose 3Drug: TRN501 - Dose 7Drug: TRN501 - Dose 8
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- SNLD, Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT06453551
- Locations
- 🇯🇵
Clinical Research Hospital Tokyo, Shinjuku-ku, Tokyo, Japan
Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- SNLD, Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06212089
- Locations
- 🇯🇵
Saiseikai Imabari Hospital, Imabari, Ehime Prefecture, Japan
News
No news found